500 related articles for article (PubMed ID: 18852650)
21. [Strategies for a greater supply of organs for transplantation].
Gridelli B; Perico N; Remuzzi G
Recenti Prog Med; 2001 Jan; 92(1):9-15. PubMed ID: 11260978
[TBL] [Abstract][Full Text] [Related]
22. Current status and future of liver transplantation.
Merion RM
Semin Liver Dis; 2010 Nov; 30(4):411-21. PubMed ID: 20960380
[TBL] [Abstract][Full Text] [Related]
23. Ethics in liver transplantation.
Kulkarni S; Cronin DC
Semin Liver Dis; 2006 Aug; 26(3):234-8. PubMed ID: 16850372
[TBL] [Abstract][Full Text] [Related]
24. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients.
Maluf DG; Edwards EB; Stravitz RT; Kauffman HM
Liver Transpl; 2009 Jun; 15(6):592-9. PubMed ID: 19479802
[TBL] [Abstract][Full Text] [Related]
25. MELD-based liver allocation: who is underserved?
Biggins SW; Bambha K
Semin Liver Dis; 2006 Aug; 26(3):211-20. PubMed ID: 16850370
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation using livers from septuagenarian and octogenarian donors: an underused strategy to reduce mortality on the waiting list.
Pirenne J; Monbaliu D; Van Gelder F; Van Hees D; Aerts R; Verslype C; Van Steenbergen W; Ferdinande P; Fevery J; Nevens F; Coosemans W; Stockman W; Lormans P
Transplant Proc; 2005 Mar; 37(2):1180-1. PubMed ID: 15848662
[TBL] [Abstract][Full Text] [Related]
27. Risk of extended criteria donors in hepatitis C virus-positive recipients.
Berenguer M
Liver Transpl; 2008 Oct; 14 Suppl 2():S45-50. PubMed ID: 18825715
[TBL] [Abstract][Full Text] [Related]
28. Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis.
Schemmer P; Nickkholgh A; Hinz U; Gerling T; Mehrabi A; Sauer P; Encke J; Friess H; Weitz J; Büchler MW; Schmidt J
Transplant Proc; 2007 Mar; 39(2):529-34. PubMed ID: 17362774
[TBL] [Abstract][Full Text] [Related]
29. The marginal liver donor--an update.
Attia M; Silva MA; Mirza DF
Transpl Int; 2008 Aug; 21(8):713-24. PubMed ID: 18492121
[TBL] [Abstract][Full Text] [Related]
30. Use of extended criteria livers decreases wait time for liver transplantation without adversely impacting posttransplant survival.
Tector AJ; Mangus RS; Chestovich P; Vianna R; Fridell JA; Milgrom ML; Sanders C; Kwo PY
Ann Surg; 2006 Sep; 244(3):439-50. PubMed ID: 16926570
[TBL] [Abstract][Full Text] [Related]
31. Split liver network: a collaborative internet-based scenario to expand the organ pool.
Valente R; Andorno E; Santori G; De Feo TM; Ghirelli R; Valente U;
Transplant Proc; 2007; 39(6):1923-6. PubMed ID: 17692654
[TBL] [Abstract][Full Text] [Related]
32. Major adverse events, pretransplant assessment and outcome prediction.
Huang HC; Lee FY; Huo TI
J Gastroenterol Hepatol; 2009 Nov; 24(11):1716-24. PubMed ID: 20136958
[TBL] [Abstract][Full Text] [Related]
33. Liver transplantation: an update 2008.
Said A; Lucey MR
Curr Opin Gastroenterol; 2008 May; 24(3):339-45. PubMed ID: 18408462
[TBL] [Abstract][Full Text] [Related]
34. Split liver transplantation: a reliable approach to expand donor pool.
Yan JQ; Becker T; Peng CH; Li HW; Klempnauer J
Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):339-44. PubMed ID: 16109512
[TBL] [Abstract][Full Text] [Related]
35. Outcome of imported liver allografts and impact on patient access to liver transplantation.
Akoad M; Wagener M; Francis F; Ahmed J; Ulizio D; Cacciarelli TV
Transplant Proc; 2006 Dec; 38(10):3564-6. PubMed ID: 17175332
[TBL] [Abstract][Full Text] [Related]
36. Assignment of steatotic livers by the Mayo model for end-stage liver disease.
Briceño J; Padillo J; Rufián S; Solórzano G; Pera C
Transpl Int; 2005 May; 18(5):577-83. PubMed ID: 15819807
[TBL] [Abstract][Full Text] [Related]
37. The marginal donor: a single-center experience in orthotopic liver transplantation.
Scuderi V; Ceriello A; Maida P; Aragiusto G; Arenga G; Carfora T; Defez M; Giuliani A; Monti GN; Santaniello W; Sicoli F; Calise F
Transplant Proc; 2006 May; 38(4):1069-73. PubMed ID: 16757267
[TBL] [Abstract][Full Text] [Related]
38. Usage and outcomes of deceased donor liver allografts with preprocurement injury from blunt trauma.
Geenen IL; Sosef MN; Shun A; Crawford M; Gallagher J; Strasser S; Stormon M; McCaughan G; Verran DJ
Liver Transpl; 2009 Mar; 15(3):321-5. PubMed ID: 19242992
[TBL] [Abstract][Full Text] [Related]
39. Model for end-stage liver disease: impact of the new deceased donor liver allocation policy in São Paulo, Brazil.
Monteiro F; Coria SA; Boni R; Pereira LA
Transplant Proc; 2009; 41(1):226-8. PubMed ID: 19249520
[TBL] [Abstract][Full Text] [Related]
40. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores.
Xia VW; Du B; Braunfeld M; Neelakanta G; Hu KQ; Nourmand H; Levin P; Enriquez R; Hiatt JR; Ghobrial RM; Farmer DG; Busuttil RW; Steadman RH
Liver Transpl; 2006 Apr; 12(4):614-20. PubMed ID: 16555319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
